Anlotinib, a novel small molecular tyrosine kinase...

International Journal of Cancer 2019 / 02

Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma

Wang, Gangyang, Sun, Mengxiong, Jiang, Yafei, Zhang, Tao, Sun, Wei, Wang, Hongsheng, Yin, Fei, Wang, Zhuoying, Sang, Weilin, Xu, Jing, Mao, Min, Zuo, Dongqing, Zhou, Zifei, Wang, Chongren, Fu, Zeze, W
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.32180
Date:
February, 2019
File:
PDF, 2.23 MB
2019
Conversion to is in progress
Conversion to is failed